NEWS

Investors keep the faith in cancer liquid biopsies

Despite slow uptake in the clinic, liquid biopsy tests incorporating methylation and other signatures are showing increasingly compelling data for non-invasive detection of cancer.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Nature Biotechnology 37, 972-974 (2019)

Updates & Corrections

  • Correction 03 June 2020: An earlier version of this article omitted mention in Table 1 of Guardant360’s FDA breakthrough device designation 15 February 2018

  • Correction 03 June 2020: The Table 1 incorrectly stated that MirXes’ products were at research stage when GastroClear has been available in Singapore since its approval on 9 May 2019 by the Singapore by the Health Sciences Authority.

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.

Sign up to Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing